Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Ursodiol
Teva Pharma GmbH
Healthy
2 trials -
V930
INOVIO PHARMACEUTICALS, INC.
Healthy
1 trial -
VCH 916
Vertex Pharmaceuticals (Australia) Pty.
HCV Infection
1 trial -
VCH-222
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
VGX-3100
INOVIO PHARMACEUTICALS, INC.
Human Papillomavirus (HPV)
1 trial -
VGX-3100
INOVIO PHARMACEUTICALS, INC.
Papillomavirus Infections
1 trial -
VGX-3400
INOVIO PHARMACEUTICALS, INC.
Healthy
1 trial -
VGX-3400X
INOVIO PHARMACEUTICALS, INC.
Healthy
1 trial -
VGX-6150
INOVIO PHARMACEUTICALS, INC.
Hepatitis C, Chronic
1 trial -
VHX-896
Vanda Pharmaceuticals Netherlands B.V.
Healthy
1 trial -
VHX-896 and iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Healthy
1 trial -
VHX-896 and iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Schizophrenia
1 trial -
VLY-686
Vanda Pharmaceuticals Netherlands B.V.
Pruritus
1 trial -
VSA001 injection
Arrowhead Pharmaceuticals Ireland Limited
Healthy Adult Volunteers
1 trial -
VX-118
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-147
Vertex Pharmaceuticals (Australia) Pty.
Focal Segmental Glomerulosclerosis (FSGS)
1 trial -
VX-150
Vertex Pharmaceuticals (Australia) Pty.
Pain
1 trial -
VX-272
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-433
Vertex Pharmaceuticals (Australia) Pty.
Narcolepsy Type 1 (NT1)
1 trial -
VX-440
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-509
Vertex Pharmaceuticals (Australia) Pty.
Healthy
1 trial -
VX-548
Vertex Pharmaceuticals (Australia) Pty.
Pain
7 trials -
VX-581
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-634
Vertex Pharmaceuticals (Australia) Pty.
Alpha 1-Antitrypsin Deficiency
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources